Purpose
We describe trends in psilocybin exposures among adolescents and young adults as reported to US poison centers over the past decade.
Methods
We queried the National Poison Data System for cases involving psilocybin during January 1, 2013–December 31, 2022. Persons aged 13–25 years were included. We examined exposures to psilocybin by demographics, clinical effects, level of care, and medical outcome.